Sino Biological Inc(301047) : financial budget report for 2022

Sino Biological Inc(301047)

Financial budget report for 2022

Special note: this budget is the internal management and control index of the company’s business plan in 2022 and does not represent the company’s profit forecast in 2022. Whether it can be realized depends on the changes of market conditions, the efforts of all employees and other factors. There are certain uncertainties. Please pay special attention to investors!

1、 Budget preparation description

Based on the 2021 financial report of the company audited by Zhitong Certified Public Accountants (special general partnership), this budget report comprehensively analyzes the expected impact of the company’s market and business development plan, policy changes, industry situation, market demand and other factors, and takes into account the current operating capacity of the company, Carefully forecast and prepare the operating conditions in 2022.

2、 Company budgeting basis

The company summarizes and analyzes the business situation in 2021, combines the company’s strategic development objectives and the overall business plan and current operating capacity in 2022, fully considers the sustainable development of the company’s business, eliminates the uncertainty caused by many factors such as market and policies, follows the current laws, regulations and accounting standards for business enterprises, and is based on objectivity, soundness Predict and prepare the business situation in 2022 in a prudent manner. This budget report includes the company and its subsidiaries.

3、 Basic assumptions

1. There are no major changes in the current relevant national and local laws, regulations and economic policies.

2. There is no significant change in the tax policy, main tax rate, exchange rate and bank credit interest rate of the country where the business is located, and there is no significant change in the company’s accounting policies and accounting estimates.

3. The prices of main raw materials and products are calculated with reference to the average level of market prices in 2021 and the prediction of 2022.

4. There are no other unforeseen and irresistible factors causing significant adverse effects.

4、 Business objectives in 2022

In 2022, the company’s non covid-19 virus related business income is expected to maintain continuous growth; Covid-19 virus related business income is affected by epidemic changes, prevention and control policies, market competition and other factors, and there is uncertainty.

Sino Biological Inc(301047) board of directors February 25, 2022

- Advertisment -